Polycaprolactone and its derivatives for drug delivery
Polymers for Advanced Technologies · 2023-10 · 34 (10) · 3296-3316
DOI: 10.1002/pat.6140 ↗Kurz gefasst
Fachartikel in der Zeitschrift Polymers for Advanced Technologies, online erschienen am 14.07.2023. Verfasst von Ranjitsinh Pawar und 5 weiteren Autor:innen. Die Arbeit wurde bisher 102-mal zitiert (Crossref) und nennt 173 Literaturangaben.
Abstract (Originalsprache)
Polycaprolactone (PCL) is polymer of 21st centuries. PCL is a biodegradable and biocompatible polymer used for various healthcare applications. This review explores the properties, synthesis, and processing of PCL. The use of PCL polymer for nanoparticles (NPs), microparticles, films, and fibers offers several advantages for biomedical applications. The review highlights the potential of PCL‐based materials for tissue engineering, drug delivery, wound healing, and implantable medical devices. We also critically analyzed challenges in PCL‐based materials and the strategies used to overcome for successful translation into clinical applications. Overall, this review provides a comprehensive overview of PCL as a valuable biomaterial for healthcare applications.
Zitieren
APA
Pawar, R., Pathan, A., Nagaraj, S., Kapare, H., Giram, P., & Wavhale, R. (2023). Polycaprolactone and its derivatives for drug delivery. Polymers for Advanced Technologies, 34(10), 3296-3316. https://doi.org/10.1002/pat.6140
Vancouver
Pawar R, Pathan A, Nagaraj S, Kapare H, Giram P, Wavhale R. Polycaprolactone and its derivatives for drug delivery. Polymers for Advanced Technologies. 2023;34(10):3296-3316. doi:10.1002/pat.6140
BibTeX
@article{Pawar2023,
author = {Pawar, Ranjitsinh and Pathan, Anam and Nagaraj, Srishti and Kapare, Harshad and Giram, Prabhanjan and Wavhale, Ravindra},
title = {Polycaprolactone and its derivatives for drug delivery},
journal = {Polymers for Advanced Technologies},
year = {2023},
volume = {34},
number = {10},
pages = {3296--3316},
doi = {10.1002/pat.6140}
}
EUVIMED